Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | TUBB1 | Q9H4B7 | 11/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | HTR1A | P08908 | 1/20 | 0.52 |
| ▸ | HTR2C | P28335 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | TUBB4A | P04350 | 6/20 | 0.50 |
| ▸ | TUBB | P07437 | 6/20 | 0.50 |
| ▸ | TUBA3C | P0DPH7 | 6/20 | 0.50 |
| ▸ | TUBA1B | P68363 | 6/20 | 0.50 |
| ▸ | TUBA4A | P68366 | 6/20 | 0.50 |
| ▸ | TUBB4B | P68371 | 6/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14173721 | 0.83 | MAPT (0.59) | GAAHTTTUBB1CYP3A4MAPT | |
| SCHEMBL31528128 | 0.81 | AMY1A (0.45) | GAAHTTTUBB1CYP3A4MAPT | |
| SCHEMBL9100974 | 0.80 | GAA (0.67) | GAAHTTTUBB1MAPTCYP1A1 | |
| SCHEMBL28310815 | 0.79 | TUBB1 (0.57) | GAAHTTTUBB1HPGDKDM4E | |
| SCHEMBL19328294 | 0.79 | TUBB1 (0.57) | GAAHTTTUBB1HPGDKDM4E | |
| SCHEMBL28278744 | 0.77 | TUBB1 (0.48) | GAAHTTTUBB1CYP3A4MAPT | |
| SCHEMBL6197316 | 0.77 | CYP3A4 (0.56) | GAAHTTTUBB1CYP3A4MAPT | |
| SCHEMBL13370881 | 0.77 | GAA (0.68) | GAATUBB1CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL4608533 | 0.77 | CYP1A1 (0.79) | GAAHTTTUBB1CYP1A1CYP1A2 | |
| SCHEMBL4608535 | 0.77 | CYP1A1 (0.79) | GAAHTTTUBB1CYP1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220002663-A1 | SELECTIVE SALMONELLA OR E. COLI CULTIVATION METHOD, COMPOSITIONS AND USES | Solus Scientific Solutions Ltd (GB) | 2022-01-06 | — | — | US | disclosed |
| US-20200399220-A1 | 3,5-DIARYLIDENYL-N-SUBSTITUTED-PIPERID-4-ONE-DERIVED INHIBITORS OF STAT3 PATHWAY ACTIVITY AND USES THEREOF | KIAKOS KONSTANTINOS (AT) | 2020-12-24 | — | — | US | disclosed |
| US-20160310528-A1 | Castration-Resistant Prostate Cancer | NUTECH VENTURES | 2016-10-27 | — | — | US | disclosed |
| US-20080096894-A1 | Anti-Bacterial Compounds | ASTON UNIVERSITY (GB) | 2008-04-24 | — | — | US | disclosed |
| US-20080096894-A1 | Anti-Bacterial Compounds | ASTON UNIVERSITY (GB) | 2008-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160310528-A1 | Castration-Resistant Prostate Cancer | UGDH, G6PD, DPYD | GAA 241/4885HTT 4119/4885TUBB1 1509/4885 |
| US-20080096894-A1 | Anti-Bacterial Compounds | MRPL21, PGLS, FOSB | GAA 135/4885HTT 4341/4885TUBB1 302/4885 |
| US-20200399220-A1 | 3,5-DIARYLIDENYL-N-SUBSTITUTED-PIPERID-4-ONE-DERIVED INHIBITORS OF STAT3 PATHWAY ACTIVITY AND USES THEREOF | STAT3, JAK2, STAT6 | GAA 4132/4885HTT 4103/4885TUBB1 1514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.